Related Experiment Video
Updated: Aug 22, 2026

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
Targeting the tumor vascular compartment to improve conventional cancer therapy
1University of Louvain Medical School, Unit of Pharmacology and Therapeutics, UCL-FATH 5349, 53 Avenue E. Mounier, B-1200 Brussels, Belgium. feron@mint.ucl.ac.be
Abstract:
The fact that a single blood vessel can support the life of thousands of tumor cells has been known for a long time. However, therapeutic strategies that aim to impair vascular development in tumors are only slowly emerging in the clinics. Nevertheless, the accumulation of data from many successful preclinical studies of the effects of a variety of drugs that target tumor vasculature provides clues that should help rationalize future treatment modalities for human tumors. Indeed, the 'old' view of an immature and non-functional vascular network within tumors has evolved and, in this article, we will show that the concept of tumor heterogeneity should be extended to the vascular compartment. In addition, we will review recent data documenting that both mature and immature vessels coexist within tumors and, importantly, that their relative density responds to a dynamic process that evolves with time and treatments.
Insights
Tumor vasculature is more complex than previously thought, featuring both mature and immature blood vessels. This heterogeneity influences cancer progression and treatment strategies, requiring dynamic therapeutic approaches.
Area of Science:
- Oncology
- Vascular Biology
- Cancer Therapeutics
Background:
- Tumor growth relies on a vascular network, historically viewed as immature and non-functional.
- Targeting tumor vasculature is a developing therapeutic strategy with promising preclinical data.
- The concept of tumor heterogeneity is now being extended to the tumor vascular compartment.
Purpose of the Study:
- To challenge the traditional view of uniform tumor vasculature.
- To highlight the coexistence of mature and immature vessels within tumors.
- To emphasize the dynamic nature of tumor vascularity in response to time and treatment.
Main Methods:
- Review of preclinical studies on anti-angiogenic and vascular-targeting drugs.
- Analysis of recent data on tumor vascular composition.
- Examination of the temporal and treatment-induced changes in tumor vasculature.
Main Results:
- Tumor vascular compartments exhibit heterogeneity, comprising both mature and immature vessels.
- The density and composition of tumor vasculature are dynamic, changing over time.
- Vascular dynamics are influenced by ongoing treatments.
Conclusions:
- The concept of tumor heterogeneity must encompass the vascular compartment.
- Understanding the dynamic coexistence of vessel types is crucial for effective cancer therapy.
- Future therapeutic strategies should consider the evolving nature of tumor vasculature.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment

